| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 354.76 | 4.2% |
| Total Income | 363.01 | 2.9% |
| Expenditure | 240.15 | 16.9% |
| PBT | 122.86 | 16.5% |
| Net Profit | 91.17 | 17.2% |
| OPM | 34.11% | 7.00pp |
| NPM | 25.11% | 6.11pp |
| EPS | 5.26 | 17.2% |
Blue Jet Healthcare Reports Q1 FY26 Results: Revenue Surges 117.8% YoY, EBITDA Margin Climbs to 34.1%
22 Jul 2025 · 22 Jul 2025, 02:01 pm
Summary
Blue Jet Healthcare Limited (BLUEJET) reported financial results for the quarter ended June 30, 2025, on July 22, 2025. The company's revenue from operations stood at Rs. 3,548 mn, a growth of 117.8% YoY. EBITDA came in at Rs. 1,210 million, up 173.3% YoY. PAT for the quarter was at Rs. 912 mn, up 141.3% compared to Q1 FY25.
Key Highlights
- 1
Revenue from operations for Q1 FY26 stood at Rs. 3,548 mn which grew 4.2% QoQ compared to Rs. 3,404 mn in Q4 FY25; up 117.8% on YoY basis compared to Rs. 1,629 mn in Q1 FY25.
- 2
EBITDA for the quarter came at Rs. 1,210 mn, down 13.6% QoQ compared to Rs. 1,400 in Q4 FY25; up 173.3% YoY compared to Rs. 443 mn in Q1 FY25.
- 3
PAT for the quarter was at Rs. 912 mn, which degrew 17.2% QoQ compared to Rs.1,101 mn; up 141.3% compared to Rs. 378 mn in Q1 FY25.
Management Comments
Mr. Shiven Arora
Blue Jet Healthcare clocked a revenue of Rs. 3,548 million, a growth of 117.8% YoY with EBITDA coming in at Rs. 1,210 million. This was primarily driven by the ramp up in Pl & API product categories. The robust growth, coupled with strong EBITDA margins, reflects our focus on operational efficiency and a solid business foundation.
Informational and educational content only. Not investment advice.